Company news
Therma Bright Inc. news in 2017
Therma Bright Inc.'s news releases, calls and decks from 2017, newest first.
The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition
December 12, 2017
The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum
December 4, 2017
The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV
November 23, 2017
The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets
November 2, 2017
The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)
October 12, 2017
The Jenex Corporation Announces Grant of Stock Options
October 6, 2017
The Jenex Corporation Terminates Exclusive License Agreement with Luminar Media Group Inc.
October 2, 2017
The Jenex Corporation Announces Approvals of Equity Financing & Move to TSX Venture Exchange (TSXV)
September 19, 2017
Jenex Reports Expected Date of Test Results for TherOZap(TM) at Inactivating the Zika Virus
September 14, 2017
Jenex is Unaware of Any Material Change
August 30, 2017
The Jenex Corporation Announces Conditional Acceptance of Reactivation from NEX to TSX Venture Exchange, TherOZap(TM) Testing and ISO 13485: 2003 Update
August 17, 2017
The Jenex Corporation Completes $317,500 Oversubscribed Non-Brokered Private Placement with Insider Participation
June 21, 2017
The Jenex Corporation Announces Equity Financing with Insider Participation
May 29, 2017
Jenex Finalizing Protocol to Test TherOZap(TM) Against the Zika Virus with University Health Network
May 23, 2017
Jenex to Test TherOZap(TM) Working Prototype and Topical Cannabidiol Oil Against the Zika and West Nile Viruses
April 18, 2017
CORRECTION FROM SOURCE: Jenex Completes Design of TherOzap(TM) Working Prototype and Signs Service Agreement with University Health Network to Initiate Testing Against the Zika and West Nile Viruses
April 7, 2017
Jenex Completes Design of TherOZap(TM) Working Prototype and Signs Service Agreement with University Heath Network to initiate testing against the Zika and West Nile Viruses
April 7, 2017
The Jenex Corporation Announces Shares For Debt Closing
April 6, 2017
Jenex Provides Update on TherOZap(TM) Working Prototype, and InterceptCS
March 6, 2017
Jenex Unaware of Any Material Change
February 27, 2017
Jenex Announces Proposed Debt Settlement
February 13, 2017
Jenex Provides Update on Next Generation Technology, TherOZap(TM) to Test Against the West Nile Virus and Zika Virus
January 24, 2017